Ficus septica plant extracts for treating Dengue virus in vitro

Introduction

Dengue fever is an acute infectious disease caused by dengue virus (DENV), which is transmitted by mosquitoes to humans; about 50 million people are infected per year worldwide (Guzman et al., 2010). According to different serotypes of the virus, four types (DENV types 1-4) are divided. Each type has the ability to cause disease. DENV infection causes varying degrees of disease manifestation, such as self-limited febrile dengue fever, skin rash or drowsiness, agitation, liver enlargement, or dengue hemorrhagic fever (DHF) and even death. A second DENV infection may lead a life-threatening dengue shock syndrome (DSS) (Abel, Liautaud & Cabie, 2012; Kyle & Harris, 2008; Martina, Koraka & Osterhaus, 2009). Currently, no specific therapy is available for the infection other than supportive treatments (Guzman et al., 2010).

The identification and use of medicinal plants for treatment of various diseases has been done throughout human history. Certain medicinal plants also show antiviral activity, such as Carissa edulis Vahl against herpes simplex virus, Geranium sanguineum L. against influenza virus A, Boehmeria nivea L. against hepatitis B virus, Saxifraga melanocentra Engl. & Irmsch. against hepatitis C virus, Lycoris radiata (L’Hér.) Herb. against severe acute respiratory syndrome-associated coronavirus and Phyllanthus amarus Schum. & Thonn. against HIV (Mukhtar et al., 2008). In addition, the neem (Azadirachta indica A. Juss.) showed potential inhibition of DENV-2 replication (Parida et al., 2002). Thus, discovering a novel antiviral medicine from medical plants would be a promising strategy.

In this study, we collected 23 plants from among Taiwanese folk medicinal plants for screening anti-DENV herbs. We also investigated the antiviral effect on Aichi virus (AiV), a pathogenic picornavirus that causes gastroenteritis. Among these plants, we found that F. septica Burm. f. could be a potential medicinal plant against DENV.

Materials and Methods

Results and Discussion

We aimed to reveal a medicinal plant candidate against DENV. We extracted 70 different crude compounds from materials of 24 plants. DENV-caused respiratory disease was revealed (Rodrigues et al., 2014; Wang et al., 2007), in addition, our previous study showed that the lung carcinoma A549 cells were well susceptible target cells for DENV, these cells have been used in the study model of viral-host interaction. Thus, A549 cells were applied as the screening model in this study (Chang, Liao & Lin, 2006). The cytotoxic effect of the extracts was evaluated in lung carcinoma A549 cells by WST-1 cell proliferation assay. Except S. divaricatus, extracts from other 23 plants revealed no cytotoxicity effect at the maximum tested concentration, 100 μg/ml. Therefore, S. divaricatus extracts were excluded in the antiviral screening (Supplementary information, Table S1).

The immunofluorescence results indicated that the F. septica materials root bark acetone (FS-(RB)-A) and fruit methanol extracts (FS-(Fr)-M), heartwood methanol extract (FS-(HW)-M), leaf acetone and methanol extracts (FS-(L)-A, FS-(L)-M), and stem methanol extract (FS-(S)-M) significantly inhibited DENV-2 infection, with IC₅₀ from 3.05 ± 0.75 to 37.46 ± 12.3μg/ml (Table 1). In addition, leaf extracts of F. sarmentosa var. henryi showed an anti-DENV-2 effect, with IC₅₀72.04 ± 14.5μg/ml, which was higher than for the extracts of F. septica (Table 1).

In addition to DENV-2, the DENV-1 was inhibited by FS-(L)-M in A549 cells (IC₅₀ = 28 ± 10.4μg/ml); however, the AiV infection was not affected by FS-(L)-M treatment (Figs. 1A and 1B). DENV infection-mediated liver disorder was reported (Samanta & Sharma, 2015; Tristao-Sa et al., 2012), therefore, the F. septica against DENV1 and DENV-2 but not AiV were also confirmed in the hematoma cell lines, HepG2 and Huh7.5 cells (Figs. 1C and 1E). Interestingly, FS-(L)-M showed more potent anti-DENV-1 and DENV-2 effect in HepG2 cells (IC₅₀ = 10.1 ± 2.4μg/ml and 12.2 ± 2.1μg/ml, respectively) then in Huh7.5 cells (IC₅₀ = 39.8 ± 6.9μg/ml and 21.9 ± 3.9μg/ml, respectively) (Figs. 1D and 1F). Moreover, skin normal fibroblasts (Wang et al., 2015), WS1 cells were used as the non-cancerous cells for testing the anti-viral effect of FS-(L)-M. The similar results showed that the FS-(L)-M inhibited DENV-1 and DENV-2 in WS1 cells with IC₅₀13.3 ± 2.6μg/ml and 10.6 ± 1.1μg/ml, respectively (Figs. 1G and 1H). A higher dose of F. septica (IC₅₀41.1 ± 6.7μg/ml) against AiV was determined in WS1 cells, which was not showed in other tested cells types. This data implicated a cell type-specific manner of AiV inhibition by F. septica. However, the precise mechanism remains to be further explored.

In order to understand whether F. septica leaf extracted with methanol, FS-(L)-M, directly inactivated DENV, we preincubated viral stocks of DENV-1, DENV-2 and AiV with a series of dilution doses of FS-(L)-M for 1 h at room temperature. After virus adsorption, the mixture of virus plus the plant extract was replaced by fresh growth medium. At 42 h after infection, the virus-infected cells were analyzed by immunofluorescence assay (Fig. 2A). FS-(L)-M significantly inhibited DENV-1 (IC₅₀ = 17.4 ± 4.6μg/ml) and DENV-2 (IC₅₀ = 15.8 ± 2.5μg/ml) but not AiV (Fig. 2B). Thus, FS-(L)-M directly impaired enveloped viral particles but not non-enveloped virus.

In this study, F. septica extracts had a promising anti-DENV-1 and -DENV-2 effect. Nevertheless, the non-enveloped picornavirus AiV was not efficiently inhibited by F. septica extract. Thus, F. septica would be a possible antiviral drug candidate against enveloped virus, such as DENV.

F. septica, a member of the family Moraceae, is widely distributed in the tropic and subtropic regions of the Western Pacific area (Weekly Asahi Encyclopedia, 1995). In Papua New Guinea, this plant has been used as a medicine to treat illnesses such as cold, fever, gastralgia and fungal and bacterial disease (Holdsworth, Hurley & Rayner, 1980). Several bioactive compounds from F. septica identified include phenanthroindolizidine and aminocarophenone- and pyrrolidine-type alkaloids (Damu et al., 2005; Damu et al., 2009; Ueda, Takagi & Shin-ya, 2009). Among them, compounds of ficuseptine, 4,6-bis-(4-methoxyphenyl)-1,2,3-trihydroindolizidinium chloride and antofine isolated from methanolic extracts of F. septica leaves showed strong antibacterial and antifungal activities (Baumgartner et al., 1990). In addition, some alkaloids, including dehydrotylophorine, dehydroantofine and tylophoridicine, isolated from methanolic extracts of F. septica twigs showed antimalarial activity (Kubo et al., 2016).

Here, we reveal a new bioactivity of F. septica against dengue virus. Importantly, an enveloped virus but not non-enveloped virus is sensitive to the extract pretreatment, which suggests that certain compounds of F. septica might disrupt the DENV envelope structure or interfere with DENV contacting cells. Moreover, the anti-DENV effect of F. septica was demonstrated in the lung and liver cell types with clinical relevant.

F. septica may be a promising medical plant against DENV. The F. septica materials root bark acetone and leaf methanol extracts showed the best anti-DENV efficacy, further identification of the antiviral compounds from these two parts of F. septica would be important for drug development.

Supplemental Information